HIV Vaccine Reported Successful in Human Trials
Sergio N. Candido - SFGN
go to original
September 6, 2013
EnglishFrenchSpanish



A new vaccine developed by Canadian researchers to prevent HIV has passed the first phase of human testing.

According to the Ontario Business Report, the team, from the Schulich School of Medicine & Dentistry at Western University, succeeded on the first phase of trials, even boosting the production of antibodies in patients it was tested on.

Lead researcher Dr. Chil-Yong Kang said the vaccine is based on a genetically-modified ‘dead’ version of the virus.

“We infect the cells with a genetically modified HIV-1,” team leader Dr. Chil-Yong Kang told Ontario Business Report. “The infected cells produce lots of virus, which we collect, purify and inactivate so that the vaccine won’t cause AIDS in recipients, but will trigger immune responses.”

Read the rest at SFGN

Photo by Ontario Business Report

We invite you to add your charity or supporting organizations' news stories and coming events to PVAngels so we can share them with the world. Do it now!

Celebrate a Healthy Lifestyle

Health and WellnessFrom activities like hiking, swimming, bike riding and yoga, to restaurants offering healthy menus, Vallarta-Nayarit is the ideal place to continue - or start - your healthy lifestyle routine.

News & Views to Staying Healthy

From the Bay & Beyond

Discover Vallarta-Nayarit

Banderas Bay offers 34 miles of incomparable coastline in the states of Jalisco and Nayarit, and home to Puerto Vallarta and Riviera Nayarit's many great destinations.